MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1.

Zhang, Yajie; Xu, Wenxia; Ni, Pan; Li, Aiping; Zhou, Jianwei; Xu, Shan

Zhang, Yajie; Xu, Wenxia; Ni, Pan; Li, Aiping; Zhou, Jianwei; Xu, Shan.

Afiliação

Zhang Y; Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University.
Xu W; Department of Molecular Cell Biology and Toxicology, School of Public Health, Nanjing Medical University; Laboratory of Cancer Biology, Biomedical Research Center, Sir Runrun Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.
Ni P; Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University.
Li A; Department of Molecular Cell Biology and Toxicology, School of Public Health, Nanjing Medical University.
Zhou J; Department of Molecular Cell Biology and Toxicology, School of Public Health, Nanjing Medical University.
Xu S; Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University.

Int J Biol Sci ; 12(12): 1437-1447, 2016.

Article em En | MEDLINE | ID: mdl-27994509

Assuntos

Calpaína/metabolismo; Cisplatino/farmacologia; Resistencia a Medicamentos Antineoplásicos/genética; MicroRNAs/genética; Neoplasias Gástricas/genética; Neoplasias Gástricas/metabolismo; Regiões 3' não Traduzidas/genética; Western Blotting; Calpaína/genética; Linhagem Celular Tumoral; Humanos; Marcação In Situ das Extremidades Cortadas; MicroRNAs/fisiologia; Reação em Cadeia da Polimerase Via Transcriptase Reversa

Palavras-chave

CAPNS1; cisplatin resistance; gastric cancer.; miR-491; miR-99a

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Calpaína / Cisplatino / Resistencia a Medicamentos Antineoplásicos / MicroRNAs Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google